Anticardiolipin co-inhibitor in normal human serum

[Genetic variant analysis in patients with autosomal recessive demyelinating Charcot-Marie-Tooth disease].

Zhonghua nei ke za zhi·2026

[Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease].

Zhonghua nei ke za zhi·2025

[Analysis of the characteristics of patients with amyotrophic lateral sclerosis with neuromuscular junction dysfunction prior to motor neuron degeneration].

Zhonghua nei ke za zhi·2024

Unexpected catalytic activity of nanorippled graphene.

Proceedings of the National Academy of Sciences of the United States of America·2023

[Electrophysiological features of patients with subacute combined degeneration].

Zhonghua yi xue za zhi·2020

Perfect proton selectivity in ion transport through two-dimensional crystals.

Nature communications·2019

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Rheumatology (Oxford, England)·2026

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Endocrine connections·2026

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Immunological medicine·2026

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

ACG case reports journal·2026

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

ACG case reports journal·2026

Related Experiment Videos

Anticardiolipin co-inhibitor in normal human serum

Related Concept Videos

[Genetic variant analysis in patients with autosomal recessive demyelinating Charcot-Marie-Tooth disease].

[Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease].

[Analysis of the characteristics of patients with amyotrophic lateral sclerosis with neuromuscular junction dysfunction prior to motor neuron degeneration].

Unexpected catalytic activity of nanorippled graphene.

[Electrophysiological features of patients with subacute combined degeneration].

Perfect proton selectivity in ion transport through two-dimensional crystals.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

Related Experiment Videos

Anticardiolipin co-inhibitor in normal human serum

Related Concept Videos

Related Articles